{
    "root": "1cc589f7-cd6d-40a6-8fce-c965e8945eae",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": {
        "text": "VITAMIN D"
    },
    "value": "20250310",
    "ingredients": [
        {
            "name": "ERGOCALCIFEROL",
            "code": "VS041H42XC"
        },
        {
            "name": "FD&C YELLOW NO. 5",
            "code": "I753WB2F1M"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "LECITHIN, SOYBEAN",
            "code": "1DI56QDM62"
        },
        {
            "name": "MEDIUM-CHAIN TRIGLYCERIDES",
            "code": "C9H2L21V7U"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "SOYBEAN OIL",
            "code": "241ATL177A"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "ETHYLENE GLYCOL MONOETHYL ETHER",
            "code": "IDK7C2HS09"
        }
    ],
    "indications": "Ergocalciferol Capsules, USP are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.",
    "contraindications": "THE RANGE BETWEEN THERAPEUTIC AND TOXIC DOSES IS NARROW.\n                  \n                     \n                        Vitamin D Resistant Rickets:\n                      12,000 to 500,000 USP Units daily.\n                  \n                     \n                        Hypoparathyroidism: \n                     50,000 to 200,000 USP Units daily concomitantly with calcium lactate 4 g, six times per day.\n                  DOSAGE MUST BE INDIVIDUALIZED UNDER CLOSE MEDICAL SUPERVISION.\n                  Calcium intake should be adequate. Blood calcium and phosphorus determinations must be made every 2 weeks or more frequently if necessary.\n                  X-rays of the bones should be taken every month until condition is corrected and stabilized.",
    "warningsAndPrecautions": "Each capsule contains Vitamin D (Ergocalciferol) 1.25 mg equivalent to 50,000 USP Units. The green colored oval shaped transparent soft gelatin capsules are imprinted with '194' in white and contain clear light yellow oily liquid.\n                  Bottles of 50 capsules (NDC: 64380-737-25)\n                  Bottles of 100 capsules (NDC: 64380-737-06)\n                  Store at 20 to 25°C (68 to 77°F) [see USP Controlled Room Temperature].\n                  Protect from light.\n                  Manufactured by:\n                  \n                     Strides Pharma Science Limited\n                  \n                  Bengaluru - 562106, India.\n                  Distributed by:\n                  \n                     Strides Pharma Inc.\n                  \n                  East Brunswick, NJ 08816\n                  \n                     Rx Only\n                  \n                  Revised: 08/2019",
    "adverseReactions": "Ergocalciferol Capsules, USP are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D."
}